FENC
Fennec Pharmaceuticals Inc
10.60$
+4.1%
vs. previous close
Closing price · As of: Oct 5, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -42.4% | -49.9% | 153.9% | -115.5% | -31.6% | -18.6% | -49.3% | -38.2% | 12.0% | -43.3% | 15.7% | 0.3% | -3.4% | |
| 1.1% | 2.5% | 2.9% | 0.7% | 0.7% | 1.5% | 0.4% | 0.3% | 0.4% | 0.0% | 0.2% | 0.1% | 0.2% | |
| 13.3% | 8.8% | 4.7% | 12.7% | 26.1% | 14.2% | 9.1% | 15.5% | 17.8% | 18.3% | 6.6% | 9.9% | 12.7% | |
| -37.7% | -31.9% | -11.1% | -47.6% | -25.0% | 8.6% | -46.5% | -33.3% | 58.4% | -67.2% | 8.0% | -19.2% | -7.1% | |
| 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | |
| – | – | – | – | 0.0% | 0.0% | – | – | – | – | – | – | – | |
| -0.2% | -0.2% | -0.1% | -1.2% | -7.6% | -0.1% | – | – | – | – | – | – | – | |
| 3.1% | 58.9% | -4.5% | 3.5% | -7.6% | -154.1% | 4.1% | -2.9% | 14.0% | 151.0% | 6.7% | 5.7% | 41.5% | |
| -39.3% | 8.9% | 149.4% | -112.0% | -39.2% | -172.7% | -45.2% | -41.1% | 26.0% | 107.7% | 22.4% | 6.0% | 38.1% | |
| -42.4% | -49.9% | 153.9% | -115.5% | -31.6% | -18.6% | -49.3% | -38.2% | 12.0% | -43.3% | 15.7% | 0.3% | -3.4% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 5, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.